<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E89C3602-0FB4-4044-A918-58966B8A10B2"><gtr:id>E89C3602-0FB4-4044-A918-58966B8A10B2</gtr:id><gtr:name>University of Reading</gtr:name><gtr:address><gtr:line1>Whiteknights House</gtr:line1><gtr:line2>PO Box 217</gtr:line2><gtr:line4>Reading</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>RG6 6AH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9B8AD86D-047F-4ED8-9132-A04425B9A510"><gtr:id>9B8AD86D-047F-4ED8-9132-A04425B9A510</gtr:id><gtr:firstName>Wendy</gtr:firstName><gtr:surname>Barclay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4CD2AF42-0F0D-4694-A7DF-16C5991E502F"><gtr:id>4CD2AF42-0F0D-4694-A7DF-16C5991E502F</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500597"><gtr:id>DC275661-D561-46AE-B856-6BD11809F553</gtr:id><gtr:title>An atlas of Influenza Hemagglutinin proteins; expression, characterisation and immunogenicity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500597</gtr:grantReference><gtr:abstractText>The avian influenza situation in SE Asia and the possibility of a new pandemic has been of great concern for the general public and has received vocal coverage in the press. Both applicants were active in responding to media queries during the recent furore and take an proactive role in relating the scientific facts to the public at large in as simple a manner as possible. This will continue during the course of this award in addition to the normal dissemination of data via publication in learned journals.</gtr:abstractText><gtr:technicalSummary>Human influenza strains derive from zoonotic events in 1918, 1957 and 1968. The latter two pandemics (Asian and Hong Kong) were almost certainly caused by re-assortment amongst viral genomes of human and avian influenza isolates, possibly in an intermediate host but the 1918 influenza (Spanish influenza) appears to have been by direct adaptation of an avian strain to growth in human cells. In all these cases the principal, though not sole, component of change is the haemagglutinin (HA), the major surface glycoprotein of the virus. Further zoonoses are inevitable and the current extensive distribution of H5N1 avian influenza in SE Asia has been taken by many to signal that a zoonotic event is imminent. The threat is real and is not restricted to the H5 subtype; other avian influenza strains (H7 and H9) have shown occasional human infection and are also of epidemic concern. This heightened concern has resurrected difficult questions about policy in the face of a new pandemic and of what can be done to have in place a range of counter-influenza measures in the event they are needed. Chief among these concerns is ?what governs if and when such strains will emerge as human pathogens and what can research offer to counter the threat and/or increase preparedness?? 

In this application we seek to generate, characterise and use a bank of HA proteins representing the entire current range of human and avian subtypes. Importantly for this application, the HAs will be expressed and characterised in a common background and in a set of common formats so that direct side-by-side comparisons can be made. The HA bank will be used to characterise receptor usage, undoubtedly one of the main factors in tropism, and also to investigate immunogenicity, a limiting factor in the development of safe influenza vaccines. As a result of extensive preparatory work, the programme will deliver all its goals within the time frame of the award and, in so doing, contribute knowledge and a definite and valuable resource to the field.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>331367</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC etc</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>55AFEF55-693B-4FB8-8535-92B2E990A8C9</gtr:id><gtr:impact>I have reeponded to many media requests for comments on avian and swine flu. I am an expert member for the SMC and was an invited panel member for briefing meeting both at the Royal Institution and at the BBC

I believe I am able to mix authoritativeness and familiarity to give an accurate but engaging view of risk and response</gtr:impact><gtr:outcomeId>229D6EE888A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Influenza Grant</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6628D1C3-661D-4036-8644-B00F2C3CB159</gtr:id><gtr:outcomeId>BBF543679B00</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have prepared a number of recombinant sources of HA and other inlfluenza proteins which we have donated to other research groups.</gtr:description><gtr:id>556A7CF1-6E50-4CE9-9492-F91155DE1873</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>3AF78C08861</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Influenza reagents</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7CA83F6F-1C61-4811-87CF-745D945E1153</gtr:id><gtr:title>Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e0c6ad08f722532cbcbd54f43288fe7"><gtr:id>8e0c6ad08f722532cbcbd54f43288fe7</gtr:id><gtr:otherNames>Mathewson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>930285B0A47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A519F807-2B75-485C-815D-F4C86D4929B1</gtr:id><gtr:title>Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52bb8372ba582a214eecb84666ce87ce"><gtr:id>52bb8372ba582a214eecb84666ce87ce</gtr:id><gtr:otherNames>Ayora-Talavera G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>384CA2B733C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56BD3AFE-D057-4156-8BAF-A803FA09CC0A</gtr:id><gtr:title>Probing the receptor interactions of an H5 avian influenza virus using a baculovirus expression system and functionalised poly(acrylic acid) ligands.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f42d698d15310b88f77e3d8ff96d1bc0"><gtr:id>f42d698d15310b88f77e3d8ff96d1bc0</gtr:id><gtr:otherNames>Barclay WS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>D4FECEF8672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1637103-580F-46A7-B4A0-74F17F8BD7A5</gtr:id><gtr:title>A single amino acid in the HA of pH1N1 2009 influenza virus affects cell tropism in human airway epithelium, but not transmission in ferrets.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b5b888461bb40a748e046f409e05ef9"><gtr:id>4b5b888461bb40a748e046f409e05ef9</gtr:id><gtr:otherNames>van Doremalen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>EVUzZgpHH4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EA7F509-E849-4761-B2A5-0584BD28545C</gtr:id><gtr:title>Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01c37f21ca87cc081d1ef26d1e59b759"><gtr:id>01c37f21ca87cc081d1ef26d1e59b759</gtr:id><gtr:otherNames>Shelton H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>657F7A9A_B657F7A9A_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>155A251B-ACCA-4905-A8E3-57CBC5AD1A27</gtr:id><gtr:title>Innovation in Vaccinology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b805334a8a5f9667cb62cfed9950f1"><gtr:id>72b805334a8a5f9667cb62cfed9950f1</gtr:id><gtr:otherNames>Loureiro S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-94-007-4542-1</gtr:isbn><gtr:outcomeId>iTVku9v9dJd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B96D5510-000E-45E8-8226-416009E3C321</gtr:id><gtr:title>Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b805334a8a5f9667cb62cfed9950f1"><gtr:id>72b805334a8a5f9667cb62cfed9950f1</gtr:id><gtr:otherNames>Loureiro S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>mRw7bJAmmJY</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500597</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>